Indrayani Biotech Ltd — Important, 30-08-2025: Company Update

The company's board has approved holding its 33rd Annual General Meeting on September 29. Significant decisions, subject to shareholder approval, include divesting from Dindigul Farm Product Limited, a material subsidiary contributing 62.83 Cr to FY25 turnover and 35.21 Cr to net worth, signaling a strategic portfolio change. The board also approved increasing authorized share capital to 85 Cr and numerous director appointments/re-appointments. Additionally, material related party transactions up to 25 Cr each with six subsidiaries were approved, highlighting inter-group business activities.